+ -Text Size

Other Resources and References TOPICS

References: Rhabdomyosarcoma detailed guide

American Cancer Society. Cancer Facts & Figures 2014. Atlanta, Ga: American Cancer Society; 2014

Breitfeld PP, Meyer WH. Rhabdomyosarcoma: New windows of opportunity. Oncologist. 2005;10:518-527.

Dome JS, Rodriguez-Galindo C, Spunt SL, Santana VM. Chapter 95: Pediatric solid tumors. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa: Elsevier; 2014.

Hawkins DS, Spunt SL, Skapek SX; COG Soft Tissue Sarcoma Committee. Children’s Oncology Group’s 2013 blueprint for research: Soft tissue sarcomas. Pediatr Blood Cancer. 2013:60:1001-1008.

Meza JL, Anderson J, Pappo AS, Meyer WH. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on Intergroup Rhabdomyosarcoma Studies III and IV: The Children’s Oncology Group. J Clin Oncol. 2006;24:3844-3851.

National Cancer Institute Physician Data Query (PDQ). Childhood Rhabdomyosarcoma Treatment. 2014. Accessed at www.cancer.gov/cancertopics/pdq/treatment/childrhabdomyosarcoma/healthprofessional on September 23, 2014.

Ognjanovic S, Linabery AM, Charbonneau B, Ross JA. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer. 2009;115:4218-4226.

Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C, Ferrari A. Comparing adult and pediatric rhabdomyosarcoma in the Surveillance, Epidemiology and End Results program, 1973 to 2005: An analysis of 2,600 patients. J Clin Oncol. 2009;27:3391-3397.

Wang L, Yustein J, Louis C, et al. Solid tumors of childhood: Rhabdomyosarcoma. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011:1780-1784.

Wexler LH, Meyer WH, Helman LJ. Rhabdomyosarcoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia Pa: Lippincott Williams & Wilkins; 2011:923-953.

Williamson D, Missiaglia E, de Reyniès A, et al. Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma. J Clin Oncol. 2010;28:2151-2158.

Last Medical Review: 11/20/2014
Last Revised: 11/21/2014